NasdaqCM - Delayed Quote • USD
60 Degrees Pharmaceuticals, Inc. (SXTP)
At close: June 7 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.23 | -0.13 | -0.47 | -0.23 |
| Low Estimate | -0.33 | -0.14 | -0.56 | -0.35 |
| High Estimate | -0.14 | -0.12 | -0.39 | -0.11 |
| Year Ago EPS | -- | 0.77 | -0.99 | -0.47 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 200k | 250k | 900k | 2.55M |
| Low Estimate | 200k | 200k | 800k | 2.1M |
| High Estimate | 200k | 300k | 1M | 3M |
| Year Ago Sales | -- | 51k | 254k | 900k |
| Sales Growth (year/est) | -- | 390.20% | 254.30% | 183.30% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | |
|---|---|---|---|---|
| EPS Est. | -- | 0.95 | -0.2 | -0.15 |
| EPS Actual | -- | 0.77 | -0.36 | 0.03 |
| Difference | -- | -0.18 | -0.16 | 0.18 |
| Surprise % | -- | -18.90% | -80.00% | 120.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.23 | -0.13 | -0.47 | -0.23 |
| 7 Days Ago | -0.23 | -0.13 | -0.47 | -0.23 |
| 30 Days Ago | -0.09 | -0.08 | -0.36 | -0.26 |
| 60 Days Ago | -0.09 | -0.08 | -0.36 | -0.26 |
| 90 Days Ago | -0.08 | -0.08 | -0.35 | -0.12 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SXTP | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 9.10% |
| Next Qtr. | -116.90% | -- | -- | 11.50% |
| Current Year | 52.50% | -- | -- | 5.70% |
| Next Year | 51.10% | -- | -- | 12.60% |
| Next 5 Years (per annum) | -- | -- | -- | 11.34% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral | 6/6/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 4/3/2024 |
| Initiated | HC Wainwright & Co.: Neutral | 10/20/2023 |
| Initiated | Ascendiant Capital: Buy | 10/2/2023 |
Related Tickers
CLDI Calidi Biotherapeutics, Inc.
0.1930
-0.52%
VIRI Virios Therapeutics, Inc.
0.2280
-3.39%
CANF Can-Fite BioPharma Ltd.
2.4700
-3.39%
KTRA Kintara Therapeutics, Inc.
0.2103
-18.11%
SCPX Scorpius Holdings, Inc.
0.1083
-9.75%
GOVX GeoVax Labs, Inc.
1.6100
-6.40%
FRES Fresh2 Group Limited
0.4375
-5.91%
INM InMed Pharmaceuticals Inc.
0.2354
-7.69%
DYAI Dyadic International, Inc.
2.0200
-8.18%
SCNI Scinai Immunotherapeutics Ltd.
2.9700
-25.94%